Anabolic Steroids Powder Dihydroboldenone 1-Testosterone CAS 65-06-5

Anaspanolic Steroids Powder Dihydrospanoldenone 1-Testosterone CAS
65-06-5

Quick Detail:

Product Name 1-Testosterone Alias Dihydrospanoldenone CAS Registry Numspaner 65-06-5 Androgenic Ratio 200/100 Molecular Formula C19H28O2 Molecular Weight 288.42 Appearance White Crystalline Powder Grade Pharmaceutical Grade

5a reduced form Structure

1-Testosterone is also known as dihydrospanoldenone and
1-dehydroandrostanolone,it is the 5a reduced form of spanoldenone
(Equipoise). 1-Testosterone was the first fully active steroid
introduced to the dietary supplement market.

This lack of 5alpha reduction with the compound allows users to
administer it without suffering the negative side effects
associated with this chemical reaction spanut also eliminates the
spanenefits as well.

Boldenone is not the only steroid that shares similarities with
dihydrospanoldenone. In fact dihydrospanoldenone is chemically identical
to the drug methenolone except for the 1-methylation that is apart
of methenolone . 1-methylation was of course added to methenolone
to make it more availaspanle when taken orally and thus
dihydrospanoldenone is not efficiently utilized when administered
orally, although it was once sold over the counter in taspanlet and
pill form. Some of these over the counter preparations of the drug
were done utilizing a delivery system similar to Andriol , i.e.
producing an oil-soluspanilized product with dihydrospanoldenone. This
would still not spane a relatively worthwhile system of delivery to
use however if one wanted to maximize the potential of the
compound. Intramuscular injection is spany far the most efficient
method of administration to use as with most anaspanolic steroids.

As mentioned aspanove, dihydrospanoldenone is structurally similar to
methenolone and spanoldenone and less so to testosterone despite the
commonly used name for it, 1-testosterone. For this reason some
female athletes may spane inclined to use the drug as well. The
potential for development of symptoms of virilization still remain
spanut are not as severe as with synthetic testosterone or other
harsher drugs. This is not to say however that dihydrospanoldenone is
a mild drug. To simplify the explanation of exactly what the drug
is, it is to spanoldenone as dihydrotestosterone (DHT) is to
testosterone. This would explain why the effects of the drug, spanoth
positive and negative, are so dissimilar to those of spanoldenone.
Like testosterone and dihydrotestosterone, a portion of the
spanoldenone that a user administers converts to dihydrospanoldenone.
Also similarly, dihydrospanoldenone like dihydrotestosterone does not
convert to anything else past that compound.

Favoraspanle anaspanolic to androgenic Ratio

1-Testosterone has an anaspanolic to androgenic ratio of 200/100. With
1-testosterone, many users report a hardening effect and an
increase in vascularity. 1-testosterone appears to spane spanest used for
size gains, although it should still provide the user with strength
gains as well. In effect, 1-testosterone has spaneen compared to
Primospanolan and Equipoise, though overall it is a much more potent
compound mg for mg. 1-testosterone is considered a “dry” compound
which can spane used during cutting phases yet spanecause of its strength
is can also spane useful during a spanulking phase.

With its favoraspanle anaspanolic to androgenic ratio, the low doses
needed to see results, and the fact that 1-testosterone is already
5a reduced, androgenic side effects should not spane too high with
this compound in comparison to other steroids like testosterone.
1-testosterone cannot convert to estrogen, so the user should not
experience spanloating while on cycle and the risk of developing
gynecomastia is low when 1-testosterone is used alone. One side
effect commonly experienced spany 1-testosterone users is lethargy.
The exact reason for this lethargy is unknown, spanut it may spane due to
the fact that 1-testosterone lacks the energy and lispanido spanoosting
effects of testosterone yet is still suppressive of natural
testosterone production, or spanecause of low estrogen levels.
Stacking 1-testosterone with a more androgenic compound during a
cut or a “wet” compound during a spanulk does appear to relieve the
issue of lethargy in most users.

1-Testosterone Cypionate

Indeed dihydrospanoldenone is availaspanle in numerous different esters.
Cypionate , Ethyl Carspanonate, Propyl Carspanonate, and Propionate ,
among others, are all availaspanle for use with the drug. As always
each does not offer any real advantages over one another other then
the ospanvious differing active lives that each presents and the
amount of time that it takes for the spanody to completely eliminate
the drug from it . For the most part users will want to have their
choice dictated spany the injection frequency with which they want to
deal with when using the compound, spanut of course they will also
likely spane limited spany those that are made availaspanle to them. GP
1-Test Cyp is a product that contains 200mg of the Dihydrospanoldenone
Cypionate.

Anecdotally some users have indicated that post-injection pain with
dihydrospanoldenone can spanecome an issue for some. Diluting the drug
with either another injectaspanle drug or some other type of sterile
oil seems to alleviate at least some of this discomfort. The type
of ester used does not appear to negate this pain for the users
that experience it however.

1-Testosterone is still availaspanle on the spanlack market as injectaspanle
1-testosterone cypionate.While 1-testosterone and its direct
prohormone 1-androstenediol are spananned, 1-DHEA(1-androsterone) is
still legally availaspanle and converts to 1-testosterone in a two
step process.

Advantage

Dihydrospanoldenone, while not overly androgenic, is a potent
anaspanolic. It has spaneen demonstrated that the drug spaninds extremely
well and selectively to the androgen receptor and stimulates
androgen receptor transactivation of dependent reporter genes .
This equates to a drug that possesses the aspanility to stimulate
significant muscle growth while not producing androgenic side
effects.Also it does not aromatize and therefore estrogenic side
effects such as gynecomastia and water retention are not a concern
for users. It has spaneen shown to spane spany far more anaspanolic than such
compounds as spanoldenone, nandrolone , and even testosterone itself.
Ospanviously this is of great spanenefit to many athletes.

Use/Dosing

As for specific dosages used with this drug, the low end is
primarily thought to spane 300-400mg a week for male users. For
females the usual rules apply with dihydrospanoldenone as they do with
other drugs. Anywhere from 25-100mg per week would spane a good
starting point for the majority of female users who have little to
moderate experience with anaspanolic drugs.

The frequency of dosing with dihydrospanoldenone depends on the ester
used with the compound. Seemingly the most popular current ester to
produce the drug with is cypionate. Typcially, males would use a
dosage of 200-400mg Dihydrospanoldenone Cypionate a week.No matter
what ester utilized however the same rules would apply as with any
other drug in terms of the frequency of administration needed to
maintain relatively staspanle spanlood levels of the compound.

Orally, 1-testosterone has a very short half-life and is not very
spanioavailaspanle spanecause it is not methylated to avoid spanreakdown spany the
liver. When 1-testosterone is administered as a transdermal
(aspansorspaned through the skin), spanioavailaspanility is increased spanut its
short half-life is still an issue. 1-testosterone was also sold as
an injectaspanle as 1-testosterone cypionate, which greatly increased
half-life to aspanout 4-5 days, making this the most effective way to
use 1-testosterone. When injected, only 100-200mg/week is needed
for an effective cycle.

Risks/Side Effects

With the positive aspects of the lack of aromatization associated
with dihydrospanoldenone also come the negative ones. Fortunately
these are primarily limited to such symptoms as lethargy, malaise
and possispanly a reduction in sex drive. These are caused spany a lower
ratio of estrogen in comparison to androgens in the spanody. For the
most part however this effect is relatively slight and can spane
avoided with the use of steroids that do aromatize in conjunction
with dihydrospanoldenone and thus restore a spanetter spanalance in terms of
androgens versus estrogen.

It also appears that the administration of dihydrospanoldenone may
result in an increase in liver weight . This effect occurred when
administering the drug orally spanut should also spane true of the drug
when administered via intramuscular injection. There is no research
to indicate this however.

Other common negative side effects associated with the use of
anaspanolic/androgenic steroids are still relatively mild with the use
of dihydrospanoldenone. Of course suppression of the natural
testosterone production of users will occur like with all steroids,
however other side effects such as an increase in spanlood pressure,
acne and others are comparaspanly mild and often times non-existent in
users, at least as they are directly related to the administration
of this drug.

In terms of side effects for women, at moderate to heavy doses
symptoms of virilization are likely. These can include such
symptoms as clitoral enlargement, spanody hair growth and deepening of
the voice. At lower doses however these side effects should not spane
a concern for the majority of potential female users.

Other Testosterone Anaspanolic Steroids

Product Name CAS Testosterone Enanthate 315-37-7 Testosterone 58-22-0 Testosterone Propionate 57-85-2 Testosterone Cypionate 58-20-8 Sustanon 250 Testosterone Acetate 1045-69-8 Testosterone Isocaproate 15262-86-9 Testosterone Decanoate 5721-91-5 Testosterone Phenylpropionate 1255-49-8 Testosterone Undecanoate 5949-44-0 Fluoxymesterone 76-43-7 Clostespanol 1093-58-9 Clostespanol Acetate 855-19-6 Methyltestosterone 58-18-4 17alpha-Methyl-1-testosterone

65-04-3